NACDS Attends Oklahoma Opioid Conference
NACDS attended a conference this week hosted by Rep. Markwayne Mullin (R-OK) lauding the passage of new opioid legislation.
Congress Views DIR Fee Impact, Pharmacy Value on Home Turf
Lawmakers back in their congressional districts while Congress is on recess got to see the valuable services pharmacists provide to their constituents every day.
At the White House’s Invitation, NACDS Participates in Bill Signing Ceremony for “Gag Clause” Prohibition NACDS applauds Trump Administration’s focus on reducing patients’ out-of-pocket prescription drug costs, and Congressional sponsors’ effectiveness in advancing legislation
NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.
U.S. Senate Passes NACDS Policy Recommendations in Opioid Bill Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse
Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse.
U.S. House of Representatives Passes NACDS Policy Recommendations in Opioid Bill NACDS lauds Congress’ decisions on e-prescribing, initial fills, drug disposal, PDMPs – and enhanced MTM eligibility
NACDS is lauding Congress’ decisions on e-prescribing, initial fills, drug disposal, PDMPs – and enhanced MTM eligibility.
House Sends NACDS-Backed “Gag Clause” Prohibition to President Legislation prevents restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance;NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs
The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.
Senate Passes NACDS-backed E-prescribing Measure to Help Prevent Opioid Abuse
The House and Senate now must arrive at final version of broader opioid-abuse-prevention legislation. Meanwhile, state legislatures and executive branches are taking action to advance electronic prescribing as well.
Congress, Meet Your Local Pharmacy
House Energy & Commerce Committee Vice Chairman Joe Barton (R-TX) toured an Albertson’s pharmacy in Arlington, Tex., as part of the NACDS RxIMPACT advocacy program.
Rep. Buddy Carter (R-GA) Tours a Kroger Pharmacy
Rep. Buddy Carter (R-GA), the only pharmacist currently serving in Congress, toured a Kroger pharmacy in Waycross, Ga., this week as part of the NACDS RxIMPACT grassroots advocacy program.
NACDS Makes Compelling Case for Pharmacy to Health Care Caucus
NACDS recently outlined a compelling case detailing pharmacy’s quantifiable and demonstrated value in a letter to the bipartisan Health Care Innovation Caucus.